NCT01917331View on ClinicalTrials.gov

Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

1,368

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

March 31, 2016

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Beclometasone/Formoterol/Glycopyrrolate

Active drug tested

DRUG

Beclometasone/Formoterol

Active comparator

Trial Locations (1)

6722

Dr Beatrix BALINT, Szeged

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT01917331 - Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD | Biotech Hunter | Biotech Hunter